Literature DB >> 16969726

[TEE-guided cardioversion in patients with atrial fibrillation without previous anticoagulation].

P Halbfass1, A Plewan, K Dennig, C Kolb, C Schmitt.   

Abstract

A total of 332 patients (mean age 65+/-10 years, 86 female) with nonvalvular atrial fibrillation (AF) of more than 48 hours duration and lack of a sufficient anticoagulation were included. After exclusion of thrombotic material in the left atrium using transesophageal echocardiography (TEE) cardioversion (CV) was performed within 24 hours. At the same time oral anticoagulation (AC) (overlapping with PTT-affecting heparinisation) was started. If thrombi were found by TEE, the examination was repeated after at least four weeks of anticoagulation. If thrombi were absent at this time, CV was performed. Periprocedural embolism was defined as primary endpoint, whereas the detection of atrial thrombi before CV was defined as secondary endpoint. In 33 of the 332 Patients (9.9%) the TEE showed a thrombus in the left atrium respectively the left atrial appendage (n=22) or thrombi could not be excluded (n=11). 383 TEEs were performed without complications in an overall of 332 patients.A total of 305 CV were performed (electrical n=300, pharmacological n=5) and during periprocedural monitoring and in the time of four weeks after CV no thromboembolic complications were observed.TEE-guided CV in patients with AF persisting for more than 48 hours and without previous AC can be considered as a method that is both safe and effective.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969726     DOI: 10.1007/s00399-006-0523-z

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  30 in total

1.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse
Journal:  Eur Heart J       Date:  2001-10       Impact factor: 29.983

2.  Low energy intracardiac cardioversion of persistent atrial fibrillation.

Authors:  M Santini; C Pandozi; S Toscano; A Castro; G Altamura; A P Jesi; G Gentilucci; M Villani; M C Scianaro
Journal:  Pacing Clin Electrophysiol       Date:  1998-12       Impact factor: 1.976

Review 3.  Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology.

Authors:  S Lévy; G Breithardt; R W Campbell; A J Camm; J C Daubert; M Allessie; E Aliot; A Capucci; F Cosio; H Crijns; L Jordaens; R N Hauer; F Lombardi; B Lüderitz
Journal:  Eur Heart J       Date:  1998-09       Impact factor: 29.983

4.  Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study.

Authors:  Karlheinz Seidl; Monika Rameken; Axel Drögemüller; Margit Vater; Andreas Brandt; Harald Schwacke; Caroline Bergmeier; Ralf Zahn; Jochen Senges
Journal:  J Am Coll Cardiol       Date:  2002-05-01       Impact factor: 24.094

5.  Left atrial chamber and appendage function after internal atrial defibrillation: a prospective and serial transesophageal echocardiographic study.

Authors:  H Omran; W Jung; R Rabahieh; R Schimpf; C Wolpert; A Hagendorff; W Fehske; B Lüderitz
Journal:  J Am Coll Cardiol       Date:  1997-01       Impact factor: 24.094

6.  Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography.

Authors:  A L Klein; R A Grimm; I W Black; D Y Leung; M K Chung; S E Vaughn; R D Murray; D P Miller; K L Arheart
Journal:  Ann Intern Med       Date:  1997-02-01       Impact factor: 25.391

7.  Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study.

Authors:  W J Manning; D I Silverman; C S Keighley; P Oettgen; P S Douglas
Journal:  J Am Coll Cardiol       Date:  1995-05       Impact factor: 24.094

8.  Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation.

Authors:  G Corrado; G Tadeo; S Beretta; L M Tagliagambe; G F Manzillo; M Spata; M Santarone
Journal:  Chest       Date:  1999-01       Impact factor: 9.410

9.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Authors:  M C Wijffels; C J Kirchhof; R Dorland; M A Allessie
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

10.  Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk.

Authors:  A Mügge; H Kühn; P Nikutta; J Grote; J A Lopez; W G Daniel
Journal:  J Am Coll Cardiol       Date:  1994-03-01       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.